fda glp-1 warning news september 2025 letters Patients taking an experimental oral drug lost significant Novo Hit With FDA Warning

Stop using it immediately and do not assume the absence of an instant reaction means it is safe, since some problematic compounds build up over time

Providers across specialties are now navigating surgical referrals, medical weight loss programs, GLP-1 therapy, and long-term nutritional support, often all within one practice

S.OikonomouE.PapamikroulisG

Alternatives and Long-Term Management Strategies For those seeking to reduce reliance on GLP-1 medications or exploring complementary approaches, several evidence-based strategies exist, though none replicate the combined metabolic effects of these drugs

T., Visessanguan, W., Karoonuthaisiri, N., & Petchkongkaew, A